Reports Q2 revenue $169.4M, consensus $186.22M. “We posted solid second quarter earnings, with Digestive Health continuing to deliver above-market growth and expanded margins,” stated Joe Woody, Avanos’s CEO. Woody continued, “Separately, we continue to deliver on our transformation priorities and remain highly focused on implementing our new pain franchise strategy outlined at our Investor Day.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AVNS:
